Submitted by Anonymous (not verified) on 18 March 2026 - 10:44
Human medicines European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma), pegfilgrastim, Date of authorisation: 19/12/2019, Revision: 10, Status: Authorised
Source: